Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

Weill Cornell researcher to study link between obesity, inflammation and breast cancer

Funded through Bloomingdale's annual Pink Campaign, The Breast Cancer Research Foundation (BCRF) is awarding a grant to Dr. Andrew J. Dannenberg of Weill Cornell Medical College on Oct. 26 to fund research into the link between obesity, inflammation and breast cancer. Dr. Dannenberg has been a BCRF grantee since 2004.

21 Oct 2011

Gastroenterologist cautions against over-prescription of acid-suppressing drugs in infants

Frequent spitting up, irritability, and unexplained crying in infants can be very distressing to parents. Pediatricians often prescribe acid-suppressing drugs for these symptoms in an effort to treat infants for gastroesophageal reflux disease (GERD); however, GERD is an uncommon cause of these symptoms in otherwise thriving infants.

21 Oct 2011

U.S. News ranks Meridian Health among 2011-2012 Best Hospitals

Jersey Shore University Medical Center, Ocean Medical Center and Riverview Medical Center, all members of Meridian Health, are included in the 2011-2012 Best Hospitals metro area rankings released by U.S. News & World Report.

19 Oct 2011

Colon cancer may be linked to a bacterium that causes appendicitis and gum disease: Study

A new study shows that a bacterium that causes appendicitis and gum disease is also found in colon tumors. Researchers suggest that it may set the stage for colorectal cancer, the second-deadliest malignancy. The bacterium – fusobacterium might play a role in determining the prognosis of colorectal cancers and shaping their treatment, according to two research teams independently reporting a relationship between the rod-shaped microbe and cancers of the lower digestive system.

18 Oct 2011

Forest Laboratories second quarter net sales increase 9.0% to $1,130.3 million

Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, announced that reported earnings per share equaled $0.91 in the second quarter of fiscal 2012. Reported earnings per share in the second quarter of fiscal 2011 were $1.00.

18 Oct 2011

New Regenstrief initiative to encourage and propel innovation

Integrating some of the best new practices of industry into the strengths of the academic research process, the Regenstrief Institute is launching an initiative to encourage and propel innovation. The Institute has over 40 years of experience as an international leader in improving healthcare delivery.

18 Oct 2011

National Centre for Bowel Research and Surgical Innovation to be set up in London

A national research centre for bowel disease is to be set up in London to bring the Cinderella area of medicine to the forefront of surgical innovation.

18 Oct 2011

International conference on polyphenols and health to be held in Sitges

The 5th International Conference on Polyphenols and Health will bring together over 700 researchers from around the world to discuss the latest findings on the polyphenolic components of food and their role in disease prevention and health promotion.

18 Oct 2011

FDA clears Cook Medical's Evolution Duodenal Controlled-Release Stent

Cook Medical announced today that its Evolution Duodenal Controlled-Release Stent was recently granted 510(k) clearance by the Food & Drug Administration.

18 Oct 2011

Takeda commences TAK-875 Phase 3 clinical trial program for type 2 diabetes

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiaries, Takeda Global Research & Development Center, Inc., and Takeda Global Research & Development Centre (Europe), Ltd., announced today the initiation of the Company's Phase 3 clinical trial program for TAK-875, an investigational therapy for type 2 diabetes.

18 Oct 2011

Gut bacteria shown to affect statin efficacy in some people

The team led by a Duke University scientist has identified three bile acids produced by gut bacteria that were evident in people who responded well to a common cholesterol-lowering drug called simvastatin. The finding, published Oct. 13, 2011, in PLoS One, demonstrates how gut bacteria can cause inherent differences in the way people digest, metabolize and benefit from substances such as drugs.

17 Oct 2011

UEI tool could allow doctors to deliver efficient, timely treatment for Crohn's disease

It's difficult for doctors to tell whether a patient with Crohn's disease has intestinal fibrosis, which requires surgery, or inflammation, which can be treated with medicine. A new imaging method might make that task easier, according to a U-M-led study.

15 Oct 2011

Researchers identify gut bacteria bile acids linked to effectiveness of statin drugs in lowering cholesterol

Statins can be effective at lowering cholesterol, but they have a perplexing tendency to work for some people and not others. Gut bacteria may be the reason.

14 Oct 2011

Patients with episodic gallbladder pain may benefit from cholecystectomy

According to a new study in Clinical Gastroenterology and Hepatology, better understanding of a patient's abdominal pain could help physicians know which patients will benefit most from surgical removal of the gallbladder.

14 Oct 2011

Narrow band imaging an equally effective alternative to chromoendoscopy for dysplasia

A new study from Spain finds that narrow band imaging appears to be a less time-consuming and equally effective alternative to chromoendoscopy for the detection of dysplasia (abnormal growths) in patients with long-standing inflammatory bowel disease.

13 Oct 2011

Shield commences two ST10 Phase 3 studies in iron deficiency anaemia

Shield Therapeutics (Shield), the independent specialty pharmaceutical company focused on the development and commercialisation of late-stage, mineral-derived hospital pharmaceuticals which address areas of high unmet medical need, today announced that the first patients have been treated in the two Phase 3 clinical studies of ST10 for the treatment of iron deficiency anaemia (IDA) in subjects with inflammatory bowel disease.

12 Oct 2011

Isis designates ISIS-AATRx candidate in collaboration with GSK

Isis Pharmaceuticals, Inc. announced today that it has designated the second development candidate, ISIS-AATRx, in its collaboration with GlaxoSmithKline

12 Oct 2011

World class scientist presents fourth Environmental Microbiology Lecture

World class scientist Professor Willem M. de Vos will explain next Monday how the microbes that are closest to our hearts - gut microbes - could underpin a new way of thinking about human biology. As well as looking at our own genes, we can now include those of our microbes in studies of human health and disease. This is a significant shift in the way we approach human biology.

11 Oct 2011

Takeda, Affymax announce data from multiple studies of peginesatide on anemia

Affymax, Inc. and Takeda Pharmaceuticals Global Research & Development Center, Inc., U.S., today announced data from multiple studies of peginesatide have been accepted for presentation at the American Society of Nephrology (ASN) Kidney Week 2011 taking place November 8-13, 2011 in Philadelphia, Pa.

11 Oct 2011

Case Western Reserve wins NCI grant to study genetic determinants of esophageal cancer

Case Western Reserve University School of Medicine and the Case Comprehensive Cancer Center are proud to announce the receipt of a highly competitive $5.4 million grant to study genetic determinants of Barrett's esophagus and esophageal adenocarcinoma.

11 Oct 2011

Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

Weill Cornell researcher to study link between obesity, inflammation and breast cancer

Gastroenterologist cautions against over-prescription of acid-suppressing drugs in infants

U.S. News ranks Meridian Health among 2011-2012 Best Hospitals

Colon cancer may be linked to a bacterium that causes appendicitis and gum disease: Study

Forest Laboratories second quarter net sales increase 9.0% to $1,130.3 million

New Regenstrief initiative to encourage and propel innovation

National Centre for Bowel Research and Surgical Innovation to be set up in London

International conference on polyphenols and health to be held in Sitges

FDA clears Cook Medical's Evolution Duodenal Controlled-Release Stent

Takeda commences TAK-875 Phase 3 clinical trial program for type 2 diabetes

Gut bacteria shown to affect statin efficacy in some people

UEI tool could allow doctors to deliver efficient, timely treatment for Crohn's disease

Researchers identify gut bacteria bile acids linked to effectiveness of statin drugs in lowering cholesterol

Patients with episodic gallbladder pain may benefit from cholecystectomy

Narrow band imaging an equally effective alternative to chromoendoscopy for dysplasia

Shield commences two ST10 Phase 3 studies in iron deficiency anaemia

Isis designates ISIS-AATRx candidate in collaboration with GSK

World class scientist presents fourth Environmental Microbiology Lecture

Takeda, Affymax announce data from multiple studies of peginesatide on anemia

Case Western Reserve wins NCI grant to study genetic determinants of esophageal cancer

Microbiology eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

Microbiology eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in